Parinaz Massoumzadeh has joined the Benzinger research group as a Bayer Healthcare/MIR Clinical Fellow in 2008 and continues her research carrier as a Staff Scientist at the Neuroimaging Laboratories. Dr. Massoumzadeh’s main research focus is clinical applications of oxygen-sensitive MRI. She is studying hypoxia in human brain tumors using advanced MR and PET imaging. Her research goal is to optimize these techniques and improve their sensitivity for diagnosis and post-intervention follow-up of brain tumors. She is also involved with “Amyloid accumulation in pre-clinical and early clinical Alzheimer's Disease” at Knight Alzheimer’s Disease Research Center (ADRC); evaluating a new radioactive compound (18F-AV-45) used in PET scans in identifying amyloid plaques in the brain and its relationship to individuals’ cognitive status.
She is honored to have represented the U.S. Department of State’s Secretary’s Office in a U.S.-Brazil exchange program for women scientists in December 2011. She enjoys hiking, biking, swimming, dancing, cooking, and spending time with family and friends.